
201 - 500 employees
Founded 2011
🏥 Healthcare
💼 Consulting
🧬 Biotechnology
Healthcare • Consulting • Biotechnology
Personalis, Inc. is at the forefront of personalized and precision cancer care. The company focuses on developing advanced genomic testing and analytics to detect cancer recurrence earlier and with higher sensitivity. Their flagship product, NeXT Personal, offers ultra-sensitive liquid biopsy tests that can identify cancer recurrence before traditional scans. Personalis works closely with healthcare professionals and biopharma partners to enhance treatment strategies and is committed to revolutionizing cancer care through innovative biomarker analysis and personalized cancer treatments.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 2 hours ago
Medical Science Liaison advancing Personalis’ personalized cancer testing and NeXT Personal MRD assay. Supporting oncology education, KOL engagement, clinical research, and field medical affairs across the West Coast.